SCHEMBL4941779

SCHEMBL4941779

CCCCN(C)S(=O)(=O)c1cc(-c2nnc(O)n2-c2ccccc2Cl)c(O)cc1O

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 9/20 0.52
TP53 P04637 1/20 0.40
ESR1 P03372 3/20 0.35
MAPT P10636 1/20 0.35
APLNR P35414 1/20 0.34
NOTUM Q6P988 1/20 0.33
LMNA P02545 2/20 0.33
TSHR P16473 2/20 0.33
HSD11B1 P28845 1/20 0.32
MEN1 O00255 1/20 0.32
USP2 O75604 1/20 0.32
ALDH1A1 P00352 1/20 0.32
ALOX15 P16050 1/20 0.32
HTT P42858 1/20 0.32
KMT2A Q03164 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GSTO1 P78417 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL645464 0.94 HSP90AA1 (0.58) HSP90AA1TP53ESR1MAPTAPLNR
SCHEMBL4937144 0.90 HSP90AA1 (0.53) HSP90AA1TP53ESR1MAPTAPLNR
SCHEMBL4933407 0.90 HSP90AA1 (0.55) HSP90AA1ESR1MAPTAPLNRNOTUM
SCHEMBL4939580 0.86 HSP90AA1 (0.58) HSP90AA1MAPTNOTUMLMNAHSD11B1
SCHEMBL646642 0.86 HSP90AA1 (0.52) HSP90AA1TP53LMNAALDH1A1SMN1; SMN2
SCHEMBL646966 0.86 HSP90AA1 (0.52) HSP90AA1TP53MAPTLMNAMEN1
SCHEMBL4940684 0.85 HSP90AA1 (0.53) HSP90AA1MAPTAPLNRLMNATSHR
SCHEMBL4938769 0.84 HSP90AA1 (0.59) HSP90AA1TP53ESR1APLNR
SCHEMBL4939661 0.84 HSP90AA1 (0.59) HSP90AA1TP53ESR1MAPTAPLNR
SCHEMBL4939553 0.84 HSP90AA1 (0.70) HSP90AA1MAPTAPLNRNOTUMHSD11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US claimed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP claimed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US claimed
CN-101119978-A HSP90-inhibiting triazole derivatives MERCK PATENT GMBH (DE) 2008-02-06 CN claimed
US-8618285-B2 Triazole derivatives MERCK PATENT GMBH (DE) 2013-12-31 US disclosed
EP-1853570-B1 HSP90-INHIBITING TRIAZOLE DERIVATIVES MERCK PATENT GMBH (DE) 2012-10-24 EP disclosed
CN-101119978-B HSP 90-inhibiting triazole derivatives MERCK PATENT GMBH 2012-05-23 CN disclosed
US-20080182857-A1 Triazole Derivatives MERCK PATENT GMBH (DE) 2008-07-31 US disclosed
CN-101119978-A HSP90-inhibiting triazole derivatives MERCK PATENT GMBH (DE) 2008-02-06 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080182857-A1 Triazole Derivatives HSP90AB1, HSP90AA1, HSP90B1 HSP90AA1 2/4885TP53 583/4885ESR1 2460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.